MyFinsight
Home
Blog
About
Back
Cash Flow
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP)
source: myfinsight.com
Net decrease in cash
and restricted cash
-$2,516K
(50.61%↑ Y/Y)
Accounts payable and
accrued expenses
$378K
(161.66%↑ Y/Y)
Right of use assets
-$160K
Prepaid expenses and
other current assets
-$160K
(-8.11%↓ Y/Y)
Stock-based compensation
$92K
(-44.58%↓ Y/Y)
Depreciation and
amortization expense
$12K
(-73.91%↓ Y/Y)
Net cash used in
operating activities
-$2,516K
(50.61%↑ Y/Y)
Canceled cashflow
$802K
Net loss
-$3,164K
(27.36%↑ Y/Y)
Operating lease
liabilities
-$83K
(43.92%↑ Y/Y)
Accounts receivable
$35K
Deposits
$19K
(-67.80%↓ Y/Y)
Tax credit
receivable
$8K
(-98.13%↓ Y/Y)
Back